These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
993 related articles for article (PubMed ID: 34358255)
1. Screening and identification of key biomarkers of papillary renal cell carcinoma by bioinformatic analysis. Xu Y; Kong D; Li Z; Qian L; Li J; Zou C PLoS One; 2021; 16(8):e0254868. PubMed ID: 34358255 [TBL] [Abstract][Full Text] [Related]
2. Bioinformatics Study Identified EGF as a Crucial Gene in Papillary Renal Cell Cancer. Qu G; Wang H; Tang C; Yang G; Xu Y Dis Markers; 2022; 2022():4761803. PubMed ID: 35655917 [TBL] [Abstract][Full Text] [Related]
3. The underlying molecular mechanism and potential drugs for treatment in papillary renal cell carcinoma: A study based on TCGA and Cmap datasets. Pang JS; Li ZK; Lin P; Wang XD; Chen G; Yan HB; Li SH Oncol Rep; 2019 Apr; 41(4):2089-2102. PubMed ID: 30816528 [TBL] [Abstract][Full Text] [Related]
4. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis. Li F; Guo P; Dong K; Guo P; Wang H; Lv X J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342 [No Abstract] [Full Text] [Related]
5. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker. Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z Gene; 2019 May; 698():9-18. PubMed ID: 30825595 [TBL] [Abstract][Full Text] [Related]
6. Identification of EGFR as a Novel Key Gene in Clear Cell Renal Cell Carcinoma (ccRCC) through Bioinformatics Analysis and Meta-Analysis. Wang S; Yu ZH; Chai KQ Biomed Res Int; 2019; 2019():6480865. PubMed ID: 30895194 [TBL] [Abstract][Full Text] [Related]
7. Bioinformatics analysis and verification of gene targets for renal clear cell carcinoma. Li F; Jin Y; Pei X; Guo P; Dong K; Wang H; Chen Y; Guo P; Meng LB; Wang Z Comput Biol Chem; 2021 Jun; 92():107453. PubMed ID: 33636636 [TBL] [Abstract][Full Text] [Related]
8. Ceruloplasmin overexpression is associated with oncogenic pathways and poorer survival rates in clear-cell renal cell carcinoma. Zhang Y; Chen Z; Chen JG; Chen XF; Gu DH; Liu ZM; Gao YD; Zheng B FEBS Open Bio; 2021 Nov; 11(11):2988-3004. PubMed ID: 34449964 [TBL] [Abstract][Full Text] [Related]
9. Identification of 4-genes model in papillary renal cell tumor microenvironment based on comprehensive analysis. Luo L; Zhou H; Su H BMC Cancer; 2021 May; 21(1):553. PubMed ID: 33993869 [TBL] [Abstract][Full Text] [Related]
10. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis. Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578 [TBL] [Abstract][Full Text] [Related]
11. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer. Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036 [TBL] [Abstract][Full Text] [Related]
12. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases. Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537 [No Abstract] [Full Text] [Related]
13. Integrated Analysis of Hub Genes and Pathways In Esophageal Carcinoma Based on NCBI's Gene Expression Omnibus (GEO) Database: A Bioinformatics Analysis. Yu-Jing T; Wen-Jing T; Biao T Med Sci Monit; 2020 Aug; 26():e923934. PubMed ID: 32756534 [TBL] [Abstract][Full Text] [Related]
14. Identification of key genes and signalling pathways in clear cell renal cell carcinoma: An integrated bioinformatics approach. S V; Balasubramanian S; Perumal E; Santhakumar K Cancer Biomark; 2024; 40(1):111-123. PubMed ID: 38427469 [TBL] [Abstract][Full Text] [Related]
15. Bioinformatics analysis of C3 and CXCR4 demonstrates their potential as prognostic biomarkers in clear cell renal cell carcinoma (ccRCC). Quan J; Bai Y; Yang Y; Han EL; Bai H; Zhang Q; Zhang D BMC Cancer; 2021 Jul; 21(1):814. PubMed ID: 34266404 [TBL] [Abstract][Full Text] [Related]
16. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis. Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116 [TBL] [Abstract][Full Text] [Related]
17. Identification of hub genes and pathways in adrenocortical carcinoma by integrated bioinformatic analysis. Guo J; Gu Y; Ma X; Zhang L; Li H; Yan Z; Han Y; Xie L; Guo X J Cell Mol Med; 2020 Apr; 24(8):4428-4438. PubMed ID: 32147961 [TBL] [Abstract][Full Text] [Related]
18. Screening, identification and validation of CCND1 and PECAM1/CD31 for predicting prognosis in renal cell carcinoma patients. Yang JF; Shi SN; Xu WH; Qiu YH; Zheng JZ; Yu K; Song XY; Li F; Wang Y; Wang R; Qu YY; Zhang HL; Zhou XQ Aging (Albany NY); 2019 Dec; 11(24):12057-12079. PubMed ID: 31850854 [TBL] [Abstract][Full Text] [Related]
19. Correlating Transcriptional Networks to Papillary Renal Cell Carcinoma Survival: A Large-Scale Coexpression Analysis and Clinical Validation. Feng X; Zhang M; Meng J; Wang Y; Liu Y; Liang C; Fan S Oncol Res; 2020 May; 28(3):285-297. PubMed ID: 31948514 [TBL] [Abstract][Full Text] [Related]
20. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma. Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]